Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multicell spheroids as a model for cell kinetic studies.

R E Durand1

  • 1Medical Biophysics Unit, B.C. Cancer Research Centre, Vancouver, Canada.

Cell and Tissue Kinetics
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.

Cytometry. Part B, Clinical cytometry·2006
Same author

Non-constant tumour blood flow--implications for therapy.

Acta oncologica (Stockholm, Sweden)·2002
Same author

Clinical relevance of intermittent tumour blood flow.

Acta oncologica (Stockholm, Sweden)·2002
Same author

Intermittent blood flow in solid tumours--an under-appreciated source of 'drug resistance'.

Cancer metastasis reviews·2002
Same author

Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity.

British journal of cancer·2001
Same author

Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.

British journal of cancer·2000

Tumor spheroids exhibit reduced cell proliferation and increased dormancy as they grow. Regrowth kinetics and drug resistance in these multicellular aggregates are explored, highlighting kinetic factors in anti-cancer drug efficacy.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • Cells cultured as multicellular spheroids display reduced proliferation and increased quiescent subpopulations with increasing size.
  • Tumor-like growth in spheroids is primarily driven by a decreasing growth fraction, with minimal cell cycle elongation.
  • Previous kinetic studies highlight the importance of growth fraction dynamics in spheroid development.

Purpose of the Study:

  • To review cellular growth kinetics in V79 Chinese hamster lung cell spheroids.
  • To describe the regrowth kinetics of cells emerging from quiescent regions within spheroids.
  • To explore the influence of regrowth and repopulation on spheroid response to anti-cancer drugs, specifically cisplatin and etoposide.

Main Methods:

  • Analysis of cellular growth kinetics in V79 cell spheroids.

Related Experiment Videos

  • Investigation of cell cycle progression and dormancy.
  • Assessment of spheroid response to cytotoxic agents (cisplatin, etoposide).

    • Main Results:

    • Spheroid growth is characterized by a progressive decrease in growth fraction and development of quiescent cells.
    • Regrowth kinetics of previously quiescent cells were characterized.
    • The study differentiated the roles of cytotoxicity and regrowth in drug response.

    Conclusions:

    • Tumor spheroid growth dynamics, including cell cycle kinetics and dormancy, influence anti-cancer drug efficacy.
    • Regrowth and repopulation are critical factors in determining spheroid response to chemotherapy.
    • Drug resistance in tumors may involve kinetic parameters related to cell proliferation and dormancy, in addition to genetic factors.